Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01804 (long intergenic non-protein coding RNA 1804) is annotated as a long non-coding RNA gene based on genomic sequence data and accession identifiers such as NCBI Gene 101926966 and Ensembl ENSG00000231031. Its classification as a lincRNA means it is transcribed as a non-coding RNA longer than 200 nucleotides without overlap with protein-coding genes. There is minimal literature characterizing its specific biochemical function or direct involvement in cellular pathways, although its locus is co-amplified with oncogenic drivers such as MYCN in rare retinoblastoma subtypes, suggesting a possible association with cancer pathogenesis. Overall, the functional significance and therapeutic relevance of LINC01804 remain largely unstudied, and no drugs or biomarkers have been developed targeting this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1804 (LINC01804).